TransMedics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Rhea-AI Summary

TransMedics Group, Inc. (Nasdaq: TMDX), a medical technology company focused on transforming organ transplant therapy, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The event will take place on Wednesday, September 4, 2024, at 1:05 p.m. Eastern Time at the Marriott Marquis New York.

Members of TransMedics' management team will engage in a fireside chat during the conference. Investors and interested parties can access a live and archived webcast of the discussion through the 'Investors' section of the TransMedics website. Additionally, the company's standard investor presentation is available for viewing on the same platform.

ANDOVER, Mass., Aug. 21, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a fireside chat at the upcoming Morgan Stanley 22^nd Annual Global Healthcare Conference at the Marriott Marquis New York. The fireside chat will take place on Wednesday, September 4, 2024, at 1:05 p.m. Eastern Time.

Event: Morgan Stanley 22^nd Annual Global Healthcare Conference
Date: Wednesday, September 4, 2024
Time: 1:05 p.m. ET

A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com. The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-morgan-stanley-22nd-annual-global-healthcare-conference-302227550.html

SOURCE TransMedics Group, Inc.

FAQ

When and where is TransMedics (TMDX) participating in the Morgan Stanley Healthcare Conference?

TransMedics (TMDX) is participating in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, at 1:05 p.m. Eastern Time. The event will be held at the Marriott Marquis New York.

How can investors access TransMedics' (TMDX) fireside chat at the Morgan Stanley conference?

Investors can access a live and archived webcast of TransMedics' (TMDX) fireside chat through the 'Investors' section of the company's website at https://investors.transmedics.com.

What is the focus of TransMedics Group (TMDX) as a medical technology company?

TransMedics Group (TMDX) is a medical technology company that focuses on transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure.

Is TransMedics' (TMDX) investor presentation available for viewing?

Yes, TransMedics' (TMDX) standard investor presentation is available for viewing on the 'Investors' section of their website at https://investors.transmedics.com.